Who owns Soleno Therapeutics, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under SOLENO THERAPEUTICS INC in our court records and SEC 8-K records (as of 2026-10-18).
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Wellington Management Group LLP (filed 2026-05-15).

Who is behind it

Soleno Therapeutics, Inc.: incorporated in Delaware; business address in Redwood City, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-13).

Officers and directors, each with the role and the filing that names them:

• Anish Bhatnagar: Executive Officer, Director (Form D, 2023-10-04)
• William Harris: Director (Form D, 2023-10-04)
• Andrew Sinclair: Director (Form D, 2023-10-04)
• Ernest Mario: Director (Form D, 2023-10-04)
• Birgitte Volck: Director (Form D, 2023-10-04)
• Gwen Melincoff: Director (Form D, 2023-10-04)
• Matthew Pauls: Director (Form D, 2023-10-04)
• James Mackaness: Executive Officer (Form D, 2023-10-04)

Money raised

Acquisitions reported on Form 8-K, Item 2.01: acquired by Neurocrine Biosciences, Inc. (2026-05-18).

Related pages

5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.